Prioritizing communicable diseases in the post-pandemic world
Covid-19 has brought attention to the potential hazard of communicable infections and the necessity for further prevention, writes Dr. Kanury V S Rao
Covid-19 has brought attention to the potential hazard of communicable infections and the necessity for further prevention, writes Dr. Kanury V S Rao
About Author: Dr. Kanury V S Rao, Co-Founder & Chief Scientific Officer (CSO), PredOmix. Dr. Kanury served as Senior Scientist and Head, Immunology Group of the International Centre for Genetic Engineering and Biotechnology (ICGEB) for over 25 years before establishing the Drug Discovery Research Centre at THSTI between 2015 to 2017. He is the recipient of several awards including the Shanti Swarup Bhatnagar Award, Millennium Medal, and Ranbaxy Research Award.